- Home
- DXCM
DXCM
DexCom Inc.
as 07-26-2024 4:00pm EST
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 44.4B | IPO Year: | 2005 |
| Target Price: | $113.71 | AVG Volume (30 days): | 5.0M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.61 | EPS Growth: | 87.21 |
| 52 Week Low/High: | $62.34 - $142.00 | Next Earning Date: | 07-25-2024 |
| Revenue: | $3,934,800,000 | Revenue Growth: | 23.05% |
| Revenue Growth (this year): | 21.97% | Revenue Growth (next year): | 19.19% |
Stock Insider Trading Activity of DexCom Inc. (DXCM)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Brown Michael Jon | DXCM | EVP Chief Legal Officer | Jun 28 '24 | Sell | $114.29 | 659 | $75,317.11 | 66,901 | SEC Form 4 |
| FOLETTA MARK G | DXCM | Director | Jun 17 '24 | Sell | $117.25 | 299 | $35,056.40 | 56,398 | SEC Form 4 |
| FOLETTA MARK G | DXCM | Director | Jun 17 '24 | Sell | $116.75 | 3,007 | $351,065.15 | 56,697 | SEC Form 4 |
| FOLETTA MARK G | DXCM | Director | Jun 17 '24 | Sell | $117.77 | 475 | $55,941.56 | 59,704 | SEC Form 4 |
| FOLETTA MARK G | DXCM | Director | Jun 17 '24 | Sell | $117.16 | 2,212 | $259,159.47 | 60,179 | SEC Form 4 |
| FOLETTA MARK G | DXCM | Director | Jun 17 '24 | Sell | $115.18 | 7 | $806.26 | 62,391 | SEC Form 4 |
| Heller Bridgette P | DXCM | Director | Jun 14 '24 | Sell | $113.55 | 1,000 | $113,550.00 | 25,349 | SEC Form 4 |
| Sylvain Jereme M | DXCM | EVP Chief Financial Officer | Jun 10 '24 | Sell | $115.05 | 745 | $85,712.85 | 84,948 | SEC Form 4 |
| Leach Jacob Steven | DXCM | EVP Chief Operating Officer | Jun 10 '24 | Sell | $115.05 | 745 | $85,712.85 | 265,577 | SEC Form 4 |
| Stern Sadie | DXCM | EVP Chief HR Officer | Jun 10 '24 | Sell | $115.05 | 427 | $49,126.95 | 75,877 | SEC Form 4 |
| Brown Michael Jon | DXCM | EVP Chief Legal Officer | May 31 '24 | Sell | $119.24 | 652 | $77,744.48 | 67,560 | SEC Form 4 |
| Dolan Matthew Vincent | DXCM | EVP Strategy and Corporate Dev | May 15 '24 | Sell | $126.58 | 2,423 | $306,703.34 | 40,075 | SEC Form 4 |
| Brown Michael Jon | DXCM | EVP Chief Legal Officer | Apr 30 '24 | Sell | $126.25 | 629 | $79,411.25 | 68,212 | SEC Form 4 |
| Dolan Matthew Vincent | DXCM | EVP Strategy and Corporate Dev | Apr 15 '24 | Sell | $137.81 | 1,990 | $274,241.90 | 42,377 | SEC Form 4 |
| SAYER KEVIN R | DXCM | President CEO and Chairman | Apr 8 '24 | Sell | $137.96 | 27,272 | $3,762,488.76 | 306,254 | SEC Form 4 |
| SAYER KEVIN R | DXCM | President CEO and Chairman | Apr 8 '24 | Sell | $138.71 | 22,361 | $3,101,647.35 | 283,893 | SEC Form 4 |
| Brown Michael Jon | DXCM | EVP Chief Legal Officer | Mar 28 '24 | Sell | $140.73 | 100 | $14,073.00 | 68,682 | SEC Form 4 |
| Brown Michael Jon | DXCM | EVP Chief Legal Officer | Mar 28 '24 | Sell | $140.02 | 2,524 | $353,399.37 | 68,782 | SEC Form 4 |
| Stern Sadie | DXCM | EVP Chief Human Resources | Mar 25 '24 | Sell | $140.00 | 4,137 | $579,180.00 | 76,304 | SEC Form 4 |
| Dolan Matthew Vincent | DXCM | EVP Strategy & Corp Dev | Mar 15 '24 | Sell | $129.18 | 1,886 | $243,641.40 | 46,684 | SEC Form 4 |
| Dolan Matthew Vincent | DXCM | EVP Strategy & Corp Dev | Mar 15 '24 | Sell | $130.77 | 1,314 | $171,832.31 | 45,370 | SEC Form 4 |
| Dolan Matthew Vincent | DXCM | EVP Strategy & Corp Dev | Mar 15 '24 | Sell | $131.39 | 1,003 | $131,785.37 | 44,367 | SEC Form 4 |
| Lawver Teri L | DXCM | EVP Chief Commercial Officer | Mar 12 '24 | Sell | $134.41 | 4,764 | $640,332.57 | 66,641 | SEC Form 4 |
| SAYER KEVIN R | DXCM | President CEO and Chairman | Mar 12 '24 | Sell | $134.41 | 29,675 | $3,988,637.52 | 384,858 | SEC Form 4 |
| SAYER KEVIN R | DXCM | President CEO and Chairman | Mar 12 '24 | Sell | $131.47 | 12,470 | $1,639,427.16 | 372,388 | SEC Form 4 |
Latest DexCom Inc. News
DXCM Breaking Stock News: Dive into DXCM Ticker-Specific Updates for Smart Investing
Investor's Business Daily
5 hours ago
Dexcom Stock Crashes 41% After Slashing Its Guidance On A 'Painfully Self-Inflicted' Quarter
MT Newswires
5 hours ago
DexCom Stock Plunges Following Guidance Cut; Results 'Disappointing,' Oppenheimer Says
TheStreet
6 hours ago
Midday movers: NVIDIA, Meta, Microsoft up, diabetes stock slumps
Barrons.com
7 hours ago
These Stocks Are Moving the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
Yahoo Finance Video
7 hours ago
June PCE inflation print, auto earnings: Morning Brief
MT Newswires
7 hours ago
Top Midday Decliners
MT Newswires
8 hours ago
DexCom Shares Fall After JPMorgan, Baird Downgrades Follow 2024 Revenue Guidance Cut
Investopedia
8 hours ago
Top Stock Movers Now: 3M, Charter Communications, Dexcom, and More
Compare DXCM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DXCM DexCom Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.